Who is sponsoring NCT03686839?

NCT03686839 is sponsored by Fabienne Marlats.

What drugs are being tested in NCT03686839?

Interventions in NCT03686839: SMR neurofeedback training to MCI.

What condition does NCT03686839 study?

NCT03686839 studies Mild Cognitive Impairment, So Stated.

Is NCT03686839 still recruiting?

NCT03686839 is currently completed. Last updated 27 September 2018.

Last reviewed 2018-09-27 · How we verify

NCT03686839: Neurofeedel

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility Study of Neurofeedback Training for Older Adults With Mild Cognitive Impairment

Completed NA Last updated 27 September 2018

What this trial tests

NA trial testing SMR neurofeedback training to MCI in Mild Cognitive Impairment, So Stated in 22 participants. Completed in 20 July 2018.

Timeline

3 March 2017

Primary endpoint
18 June 2018

20 July 2018

Quick facts

Lead sponsor	Fabienne Marlats
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	22
Start date	3 March 2017
Primary completion	18 June 2018
Estimated completion	20 July 2018
Sites	1 location across France

Drugs / interventions tested

SMR neurofeedback training to MCI

Conditions studied

Mild Cognitive Impairment, So Stated — all drugs for Mild Cognitive Impairment, So Stated →

Sponsor

Fabienne Marlats

Who can join

60 and older, any sex, with Mild Cognitive Impairment, So Stated. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a non-pharmacological study evaluating the feasibility of a neurofeedback training program in elderly with mild cognitive impairment (MCI) according to recruitment, retention, attendance, acceptability data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of SMR neurofeedback training to MCI

Trials testing the same drug.

NCT03855319 — Neurofeedback Improves Cognitive Performance and EEG Activity in Elderly With Mild Cognitive Impairment · NA · completed

Other Fabienne Marlats trials

Trials by the same sponsor.

NCT03855319 — Neurofeedback Improves Cognitive Performance and EEG Activity in Elderly With Mild Cognitive Impairment · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03686839 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fabienne Marlats
Last refreshed: 27 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03686839.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing